For instance, the engineered tumor-targeting probiotic Escherichia coli Nissle 1917 significantly promotes the secretion of catalase within the tumor microenvironment, catalyzing the conversion of H2O2 produced by tumor cells into O2, and enhancing ROS production under hypoxic conditions. The gene discussed is CAT; the disease is neoplasm.